Literature DB >> 22873553

Prevalence and monitoring of oligosecretory myeloma.

Dirk Larson, Robert A Kyle, S Vincent Rajkumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22873553     DOI： 10.1056/NEJMc1206740

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study.

Authors:  Xiao-Qi Qin; Gang An; Zeng-Jun Li; Lan-Ting Liu; Yan Xu; Lin-Hua Yang; Yan-Ping Ma; Shu-Hui Deng; Wei-Wei Sui; Yu Qin; Xiao-Yan Feng; Mei-Rong Zang; Wen-Juan Yang; Yan-Ru Zhang; Shu-Hua Yi; Ting-Yu Wang; Rui Lv; De-Hui Zou; Yao-Zhong Zhao; Lu-Gui Qiu
Journal:  Blood Adv       Date:  2019-03-12

2.  Quantification of bone-marrow plasma cell levels using various International Myeloma Working Group response criteria in patients with multiple myeloma.

Authors:  Kentaro Narita; Hiroki Kobayashi; Yoshiaki Abe; Hiroaki Kitadate; Masami Takeuchi; Kosei Matsue
Journal:  Int J Hematol       Date:  2018-07-05       Impact factor: 2.490

Review 3.  Progress of modern imaging modalities in multiple myeloma.

Authors:  Toshiki Terao; Kosei Matsue
Journal:  Int J Hematol       Date:  2022-05-09       Impact factor: 2.490

4.  The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide.

Authors:  Tzu-Fei Wang; Rohan Ahluwalia; Mark A Fiala; Kathryn M Trinkaus; Doug P Cox; Matthew Jaenicke; Caitlin C Moliske; Kenneth R Carson; Tanya M Wildes; Michael H Tomasson; Keith E Stockerl-Goldstein; Ravi Vij
Journal:  Leuk Lymphoma       Date:  2013-06-24

5.  Monitoring multiple myeloma by quantification of recurrent mutations in serum.

Authors:  Even Holth Rustad; Eivind Coward; Emilie R Skytøen; Kristine Misund; Toril Holien; Therese Standal; Magne Børset; Vidar Beisvag; Ola Myklebost; Leonardo A Meza-Zepeda; Hong Yan Dai; Anders Sundan; Anders Waage
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

6.  Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study.

Authors:  Uros Markovic; Alessandra Romano; Claudia Bellofiore; Annalisa Condorelli; Bruno Garibaldi; Anna Bulla; Andrea Duminuco; Vittorio Del Fabro; Francesco Di Raimondo; Concetta Conticello
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

7.  Oligosecretory Myeloma With Amyloidosis and Alopecia.

Authors:  Anum Bilal; Paul Der Mesropian; Franklin Lam; Gulvahid Shaikh
Journal:  J Investig Med High Impact Case Rep       Date:  2018-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.